Form D · Biotechnology
Revolutions Medical CORP
Charleston, SC · CIK 0001041009
Offering snapshot reported Mar 25, 2011 · SEC filing
- Reported sold
- $1.05M Offering amount: $1.05M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1.05M Reported outside-investor minimum
- First sale
- Feb 24, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2011 | Initial | $1,050,000 | No comparison | 1 | SEC filing |
| Nov 25, 2009 | Initial | $768,000 | No comparison | 43 | SEC filing |
| Nov 10, 2009 | Initial | $758,000 | No comparison | 42 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-157336
Source: Form D, filed Mar 25, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Beahm | Director |
| Thomas O'brien | Director |
| Rondald L Wheet | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
670 Marina Drive 3 Rd Floor
Charleston, SC, 29492
Charleston, SC, 29492